An interventional study of SOAR in Sleep Health, Binge Eating and Disordered Eating, sponsored by University of Nevada, Las Vegas. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-08.
Sponsored by University of Nevada, Las Vegas · Not applicable, Interventional, and Treatment
The purpose of this pilot study is to evaluate the usability and feasibility of SOAR (Sleep Optimization to Aid Recovery), a brief and self-guided digital program designed to share evidence-based sleep hygiene information with individuals seeking treatment for an eating disorder. The SOAR program delivers well-established recommendations promoted by the National Sleep Foundation and other professional sleep health organizations. The purpose of this study is not to test a new treatment or intervention per se, but rather to examine how effectively this existing information can be delivered through a digital platform to people preparing for or engaged in eating disorder treatment. By providing these evidence-based strategies in a user-friendly and accessible format, SOAR aims to support healthy sleep habits that may enhance overall well-being and facilitate recovery.
The investigators will compare SOAR against a control condition, which would be no intervention (treatment-as-usual). Participants randomized to the control will receive access to SOAR after the follow-up period has ended, if they wish to use it.
173 studies on the registry are indexed under Bulimia; 33 are open to participants now.
This study's planned enrollment of 154 is above the median of 60 across 143 interventional studies indexed under Bulimia.
Browse Bulimia studies →University of Nevada, Las Vegas is the lead sponsor of 75 studies on the registry; 22 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 2 (40%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The SOAR program is designed to help improve sleep health for people beginning eating disorder treatment. The packaging of the SOAR intervention (e.g., videos) and the targeting of these materials to an eating disorder treatment context represent the novel experimental contributions of this program.
Behavioral: SOAR
The current standard of care is no intervention. The no intervention condition thus is treatment-as-usual. Participants will receive the option to access the active intervention at the conclusion of their study participation. These participants will complete the baseline session and the follow-up survey only.
SOAR is administered using the REDCap platform. It consists of a series of videos about the science behind the link between eating disorders and sleep and best practices and tips for sleep health recommended by leading sleep health organizations. SOAR includes sleep hygiene information, videos on stimulus control (a best practices intervention for insomnia), and instructions for setting a regular sleep/wake time. At the end of the program, users will create a sleep action plan using the information they learned from SOAR.
PROMIS Sleep Disturbance
Scores range from 8 to 40 with higher scores indicating greater sleep disturbance.
Time frame: Baseline and one-month follow-up
PROMIS Sleep Impairment
Scores range from 8 to 40 with higher scores indicating greater impairment from sleep problems.
Time frame: Baseline and one-month follow-up
Acceptability of Intervention Measure (AIM)
Scores range from 1 to 5 with higher scores indicating greater acceptability of the intervention.
Time frame: Within 24 hours post-intervention
Intervention Appropriateness Measure (IAM)
Scores range from 1 to 5 with higher scores indicating greater appropriateness of the intervention.
Time frame: Within 24 hours post-intervention
Feasibility of Intervention Measure (FIM)
Scores range from 1 to 5 with higher scores indicating greater feasibility of the intervention.
Time frame: Within 24 hours post-intervention
System Usability Scale (SUS)
Scores range from 0 to 100 with higher scores indicating greater usability of the intervention.
Time frame: Within 24 hours post-intervention
Sleep Hygiene Index
Scores range from 13-65 with higher global scores indicative of more maladaptive sleep hygiene practices.
Time frame: Baseline and one-month follow-up
Sleep Health (RU-SATED)
Scores range from 0 to 14 with higher scores indicating better sleep health
Time frame: Baseline and one-month follow-up
Eating Disorder-15
Scores for the two factors (Weight \& Shape Concerns and Eating Concerns) and the total score are presented as an average score (between 0 to 6) with a higher score indicating more eating-disordered cognitions and behaviors.
Time frame: Baseline and one-month follow-up
Generalized Anxiety Disorder-7
Scores range from 0 to 21 with higher scores indicate greater generalized anxiety disorder pathology.
Time frame: Baseline and one-month follow-up
Patient Health Questionnaire-8
Scores range from 0 to 24 with higher scores indicating greater depressive pathology. The suicidality question from the PHQ-9 will not be administered.
Time frame: Baseline and one-month follow-up
Self-Efficacy Scale
Scores range from 10 to 40 with higher scores indicating greater self-efficacy.
Time frame: Baseline and one-month follow-up
Clinical Impairment Asssessment
Scores range from 0 to 48 with higher scores indicating greater impairment from eating disorder symptoms.
Time frame: Baseline and one-month follow-up
No study locations are listed for this record.
Plan to share: Yes — All IPD collected throughout the trial will be included; however, any personal information that could identify participants will be removed or recoded prior to sharing.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: IPD will be available upon reasonable request after the completion of the trial.
Access criteria: Researchers at public or private institutions may email the study team to request access to the IPD. A data dictionary of variable names will be publicly posted to the study's OSF page.
No publications or documents are linked to this record.
Start is estimated for May 2026; primary completion for Mar 2028, 22 months later.
Of 68 non-industry interventional studies with no phase under Bulimia, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 52. This study's planned 22 months is below that.
Counting every sponsor, half of 70 studies reached it within 26 months; a quarter within 10 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Nevada, Las Vegas